From dealer to doctor: A case study examining how Purdue Pharma sought to leverage racial health disparities to attenuate flagging OxyContin sales

Keyphrases

• Racial Health Disparities 100%
• Dealers 100%
• Structural Racism 100%
• OxyContin 100%
• Purdue Pharma 100%
• Opioids 66%
• Opioid Epidemic 66%
• Project Tango 66%
• Industry Documents 66%
• Medical Care 33%
• Policy Documents 33%
• Drug Target 33%
• Black Population 33%
• Intervention Strategies 33%
• Resource Use 33%
• Regulatory Pressure 33%
• Medicaid 33%
• Black Women 33%
• One-part 33%
• Health Disparities 33%
• Pain Management 33%
• New Customers 33%
• Substance Abuse Treatment 33%
• Johns Hopkins 33%
• Asian Patients 33%
• Drug Sales 33%
• Latino Populations 33%
• Rage 33%
• Federal Regulations 33%
• Medically Underserved 33%
• Negative Media Attention 33%
• Substance Use Disorder Treatment 33%
• State Regulatory Policy 33%
• Pressure Medium 33%
• Chevron Doctrine 33%
• Underserved Patients 33%
• Indigenous Patients 33%
• Latino Patients 33%
• Counter-intervention 33%
• Subnational Level 33%

Social Sciences

• Sales 100%
• Racial health disparities 100%
• Intervention Strategy 33%
• Health Disparity 33%
• Regulatory Policy 33%
• Policy Document 33%
• Physical Dependence 33%
• Substance Use 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Oxycodone 100%
• Health Disparity 100%
• Drug Dependence 50%